IFNA1 and systemic lupus erythematosus: On the contrary, fully humanized monoclonal antibodies against IFN-α (MEDI-545, Medimmune, Gaithersburg, MD, USA) are under clinical experimentation for use in the treatment of autoimmune conditions such as systemic lupus erythematosus (SLE).